Issue Contents:
SCIENCE PULSE: Blastocyst Vitrification: The First 2 Years PATIENT ODYSSEY: Getting the Best of Both Worlds through IVF
FROM US TO YOU: Dr. Conaghan & Dr. Givens Attend ABB Conference ASK THE EXPERT: Age-Related Sub-Fertility
ELECTRONIC MEDICAL RECORDS IMPLEMENTATION AT PFC FREE SEMINAR: Overcoming Infertility: The Next Step to Parenthood


Pacific Fertility Center


55 Francisco Street,
Suite 500
San Francisco,
CA 94133
TEL: 888-834-3095
FAX: 415-834-3080
pacificfertilitycenter.com
[email protected]



Our Promise

As a unified team,
guided by the highest
ethical standards, we
provide our patients with
the best quality,
individualized,
compassionate fertility
care.





Top 5 Reasons to Choose Pacific Fertility

1. All of our physicians
are subspecialty
board certified as
Infertility Specialists.

2. Our laboratory has
certified embryologists
and Ph.D. educated
scientists.

3. Our clinical and
administrative team
provides quality,
individualized and
compassionate care.

4. Our excellent
success rates rank us
among the best
programs in the nation.

5. We offer the most
technologically
advanced and innovative services.


A human embryo
In 2007, PFC took the bold step of changing the way we freeze embryos. Traditionally, embryos are frozen using a �slow-freeze� protocol where they are exposed to weak concentrations of cryoprotectants before being cooled slowly (-0.3 �C/min) for 2-3 hours. This system has worked well over the years, but recent advances in an ultra-rapid freezing technology showed great promise. PFC began looking at a technology called vitrification in 2006. After seeing wonderful results from in-house trials we were able to phase vitrification into our practice in March of 2007. By June, we had stopped slowfreezing completely. In late 2008, after our 200th thawing cycle with vitrified embryos, we examined the data.

From our first 2 years of thaws, we recovered 94% (423/448) of embryos vitrified, and 94% (397/423) of these were alive when the thawing process was completed. The total number viable was 88% (397/44 8). These numbers compare well to those reported in the scientific literature, but we continue to improve the process and strive for even better results. Vitrification uses tiny straws called �cryotips� to house the embryos during the process, and uses higher concentrations of cryoprotectants than slowfreezing. These details make the procedure technically challenging, which may sometimes result in the loss of an embryo. The tiny straws can crack or break due to the extreme physical force that they endure during freezing and thawing. If this happens, the embryo in the straw cannot be recovered. This lack of recovery or survival is a complication of any freezing procedure. We continue to go to great lengths to minimize these losses, some of which are unavoidable.

Frozen embryos are stored in liquid nitrogen

We have completed 202 thawing cycles to date (A thawing cycle refers to a treatment cycle wherein a patient returns to use vitrified embryos and we thaw and transfer 1 or more to her uterus at the same time). Ninety-seven of these 202 cycles (48%) resulted in an established clinical pregnancy. The average number of embryos transferred per cycle was 1.9 and the implantation rate (embryos implanting out of embryos transferred) was 31%.

The vitrification procedure and materials continue to evolve. Irvine Scientific, the company that manufactures the cryotips, continues to improve their product. They are working extremely hard to eliminate defects that may lead to straw failure during cooling and thawing. At the same time, PFC continues to evaluate new ways to improve embryo survival and implantation rates. This year, we are investigating a process which artificially collapses blastocysts prior to vitrification. We will also be investigating the use of assisted hatching with thawed embryos. Be sure to watch these pages for exciting updates in the months to come.




We never planned nor expected to have twins, but we feel exceptionally fortunate to have the best of both worlds: a boy and a girl. It was a great hand of luck, which, minus the infertility part, has been our story from the beginning of this journey.

We knew we wanted kiddos, but like many couples wanting kids nowadays, we thought we had a good reason to postpone starting a family. Our plans were to travel the world, come back home and then grow kids. We sold everything we owned, bought two motorcycles and traveled across 30 countries over the span of three years before returning to San Francisco. Only later did we discover that infertility would be our issue.

We tried to conceive on our own for a year without luck. When we decided to get preliminary blood work to help solve our mystery, each test came back normal. Our prognosis wasn't good: unexplained infertility.

I spent the next three weeks researching our fertility options online�looking at doctors and clinics, and comparing their success rates and patient reviews. During my research process, I learned how quickly the chances of having a family were dwindling for a couple of our age. A 40 year old healthy woman has around a 25% chance of a live birth through IVF. While a woman over 42 years of age, has a 5% or less chance of conceiving. I was almost 41 years old.

I felt very good about Pacific Fertility Center as all five of the doctors were researchers in the field of fertility with exceptional resumes. Furthermore, as practitioners, they seemed more experienced than most, in working with women past age 40. I chose the first doctor I spoke with, Doctor Ryan, based on her online profile. She was straightforward, and took the time to explain our treatment to us both verbally and visually (drawing out diagrams). She has a rare ability to conduct a professional yet personal relationship. She is genuinely warm, personable, and interested in her patients. Pierre and I knew after one meeting that we wanted to work with her.

The injections and the medications became a kind of ritual for us. The experience brought Pierre and I closer. Of the seven eggs collected, four developed into embryos. On the third day, all four were transferred and we started to wait, hopeful it would "work". Six weeks later, late in the evening, I began to bleed and was sure I had miscarried. For the first time I realized what it meant to me to have a child. I wouldn't let myself believe I had miscarried, but I also recognized the emotional tail-spin I'd go into if I had in fact lost the pregnancy. We both must have had the saddest night of our lives. Early the next morning, I went in for an emergency appointment. The image came up on the ultrasound screen and, within seconds, the doctor turned to me and exclaimed: "You have twins!" Pierre and I looked at each other elated. Twins! It was the best fortune imaginable.

Max and Emmanuelle are now 9 months old. We barely remember life before them. They are healthy, incredibly good-natured babies. Pacific Fertility Center was the best choice for us, but not entirely based on our (and Dr Ryan's!) success. We knew it was a one-shot deal and the result, a girl and a boy, could not have been better.

For parents thinking about using IVF, I would recommend setting a limit in the number of attempts before you begin treatment. Knowing we were with the best doctors allowed us to approach the procedure in a more relaxed way. Knowing our odds, however, we did feel like this was our last hope. Now we find it more amusing and gratifying to find ourselves looking for our own characteristics in our kids. We see Max and Emmanuelle as little individuals who have been placed into our care, two beautiful and unique little people whose personas are going to blossom in front of our eyes.

We are incredibly grateful to Dr. Ryan and the team at PFC for allowing us to know the joy of giving birth. However, we are most grateful to be parents. Above all else, it is this unconditional love that lasts 18 years and beyond, that really defines parenthood. Even if your fertility issue doesn�t permit the use of your own genes, know that you still will be a very loving, loved and fulfilled parent.

--Submitted by Merritt Grooms




In January, Dr. Carolyn Givens and I attended a meeting in Hawaii organized by the American Board of Bioanalysts (ABB). This organization board certifies and licenses embryologists, andrologists, and a number of other laboratory specialists in the United States. Our meeting was under the direction of the College of Reproductive Biology, a special interest group within the ABB and for which I am the immediate past Chair.

The meeting was small and intimate, a situation always welcomed among reproductive biology professionals. The location allowed for good interaction with embryologists from Japan who have always been a great source of ideas and innovation within our specialty.

In fact, the highlight of the meeting was a series of videos shown by Dr. Yasuyuki Mio from the Mio Fertility Clinic in Yonago, Japan. He was able to take time-lapse cinematography of human embryos in culture, and as a result reported some novel observations on how oocytes fertilize and how embryos develop. The actual moment of sperm entry into the oocyte was recorded and it was possible to see that human oocytes form a fertilization cone (a membrane that helps bring the sperm into the oocyte), shortly after sperm entry. The events that follow (2nd polar body extrusion, which is the egg extruding a set of chromosomes, and pronuclear formation, alignment of the nuclei from the egg and sperm) occurred as expected, but for the first time the male and the female nuclei could be distinguished from each other.

After fertilization, the embryos were seen to change dramatically as they developed. In particular, they appeared more disorganized and untidy immediately after a cell division event and more symmetrical and organized several hours later. This discovery has implications for those embryos that sometimes may appear poorly. It suggests that they may look better later in the day when they are clear of the cell division process. Another important observation regarding blastocysts, is that those that develop 2 inner cell masses (ICM: the precursor cells of the fetus) do so in a predictable way. At PFC, we avoid using embryos with two ICMs whenever possible, as they are likely to lead to the formation of identical twins. A normal embryo should have only a single ICM. Currently, it is possible that one of the ICMs may be small enough to avoid detection. The observation was made that the fine cellular bridges within the embryo cavity appear to correlate to the presence of an extra ICM.

Another notable presentation was that of Dr. Tetsunori Mukaida, of Hiroshima HART Clinic, on sperm morphology. He demonstrated that observing sperm under ultra-high magnification can show structural defects that are not always visible when using standard microscopes. While magnifying sperm thousands of times has its difficulties, Dr. Mukaida reported that sperm with subtle physical defects have a much lower chance of making an embryo that can become a baby. Sperm that are close to perfect in size, shape and structure are difficult to find in any sperm sample and it can take hours just to find a few ideal sperm. However, the extra effort may be worthwhile, especially in patients that have had a previous IVF cycle where the embryos did not develop well or implant after transfer. PFC is currently looking into this technology and we will report more details in a future issue of Fertility Flash.

Attending meetings like this and keeping up with the latest developments in our field is an important part of the culture at PFC. We share the load of traveling to educational events and are always excited to bring home ideas and thoughts to share with our colleagues. PFC is committed to implementing the latest technology and innovations to maximize pregnancy rates for our patients. We will continue to stay updated with all of the research and development in our specialty.

Joe Conaghan, Ph.D., HCLD is PFC�s laboratory director. Dr. Conaghan is internationally recognized for his work on improving embryo culture conditions. His interests include developing programs for the treatment of severe male factor infertility; diagnosis of genetic disease in embryos; and improved embryo culture.


Carolyn Givens, M.D. was the first in San Francisco to successfully initiate a pregnancy using intracytoplasmic sperm injection (ICSI). She currently co-directs the Bay Area Pre-Implantation Genetic Diagnosis Program (PGD) and is director of PFC�s PGD program.





Q: I�m 38 years old and have been trying to get pregnant for about a year. All of my lab tests and my husband�s semen analysis have been normal. What do you think is the problem?

A: For women in their late 30s, it is naturally going to take longer to get pregnant. They are experiencing what I like to call �age-related sub-fertility.� Some may be lucky and become pregnant right away. However, for the majority of women, as we age fewer of the eggs we ovulate are chromosomally normal; and therefore fewer ovulations result in the release of a normal egg. It just may take more ovulations before that normal egg is released, fertilized, implants, and succeeds in becoming a baby. It is estimated that about 1 in 5 eggs are normal at age 35, about 1 in 10 at age 40, and only 1 in 25 at age 45. So, at age 38, if about 1 in 8 eggs are normal, you may have only 1 or 2 chances a year for successful conception. If your intercourse was not well-timed that cycle or there was some other subtle inefficiency, the chance for conception may be lost. The catch-22 with age-related sub-fertility is that it takes longer to get pregnant and meanwhile, you are getting older and your egg quality is also declining. For this reason, many women seek treatment with fertility medications or IVF as they get older. These treatments can increase the number of eggs produced and exposed to sperm in a single month, thus improving the odds that normal eggs will be found. The good news is that for most women still in their 30s, fertility treatments for age-related sub-fertility are often successful.

-- Carolyn Givens, M.D.




Pacific Fertility Center (PFC) is happy to announce the implementation of its Electronic Medical Records (EMR) system. After a thorough workflow analysis of PFC�s clinical, administrative, and billing processes, EMR Manager Christian Marquez, and IT Director Dave Bjorklund have begun the initial phase of EMR implementation.

PFC�s mission has always focused on providing quality infertility care for its patients, and with the chosen HIPPA-compliant EMR system, eIVF, that mission will be enhanced. HIPPA is the system of federal guidelines to protect patient confidentiality and eIVF is the software system from the company Practice Highway, that is designed for fertility and IVF practices.

Once the EMR system is fully implemented, there will be many benefits for PFC patients. One example would be the increased efficiency of the medical records department. Currently, as in many medical offices, each patient has a paper medical chart that is approximately 9 x 12 inches in size and about 1-2 inches thick. All medical reports and clinical notes are filed within designated sections of the chart. The chart must be located for every patient visit or telephone call. Many times, the chart may not be in the medical records filing room due to handling by office staff involved in the care of a patients� treatment. As you can imagine, PFC�s three file clerks often spend a great deal of time locating charts and transporting them to various locations within the organization.

With an EMR system, all medical reports and notes normally recorded and stored in a medical chart will soon be entered or scanned into a computerized database for quick and efficient access by any authorized personnel from any office location. The software system is designed to be convenient to access by authorized PFC staff but adequately protected from inappropriate viewing or use by any other individuals.

In the near future, patients will be able to access their medical treatment plan or ask questions through eIVF�s secure online patient portal, accessed through PFC�s website.

In addition, if authorized by the patient, referral physicians may have online access to the patient�s medical record.

These types of changes will enhance the patient and doctor relationship, and at the same time improve productivity and efficiency within the PFC organization. We are excited about this transition to a paperless medical record. We will keep you informed of our progress.

-- Christian Marquez, EMR Manager

Free Seminar

Overcoming Infertility:
The Next Step to Parenthood


Ask • Meet • Learn

Led by PFC's Infertility Specialists

Dates:
Wednesday, June 17
Wednesday, July 15
Wednesday, August 19

Location:
Pacific Fertility Center
55 Francisco Street, 5th Floor
San Francisco, CA 94133

Contact:
Please call for reservations,
directions and parking information:
888-834-3095

Sign Up Now

Thank you for your interest in subscribing to Pacific Fertility Center’s free monthly newsletter. In order to better protect your privacy, we have a new secure subscription/log in form. We respect your privacy: Your email remains confidential and will not be shared or sold.
Please click here to change your subscription preferences.

-- Best regards from all of us at Pacific Fertility Center.


Copyright � 2009 Pacific Fertility Center and Its Licensors. All rights reserved.